tiprankstipranks

Bioventix CFO Increases Stake Through Share Purchase

Story Highlights
Bioventix CFO Increases Stake Through Share Purchase

Confident Investing Starts Here:

Bioventix ( (GB:BVXP) ) has provided an announcement.

Bioventix plc announced that its Chief Financial Officer, Bruce Hiscock, has purchased 61 ordinary shares of the company under a dividend reinvestment plan. The purchase slightly increased Hiscock’s stake in the company to approximately 0.02 percent of the issued share capital, demonstrating a continued commitment to the company’s growth and market position.

More about Bioventix

Bioventix plc is a UK-based company that specializes in the development and commercial supply of high-affinity monoclonal antibodies, primarily for applications in clinical diagnostics.

YTD Price Performance: -22.66%

Average Trading Volume: 8,136

Technical Sentiment Consensus Rating: Buy

Current Market Cap: £167M

For an in-depth examination of BVXP stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1